On January 5, 2021 Atomwise, a technology-enabled pharmaceutical company leveraging the power of artificial intelligence (AI) to revolutionize small molecule drug discovery, reported that it has been invited to present next week at the 40th Annual J.P. Morgan Healthcare Conference (Press release, Atomwise, JAN 5, 2022, View Source [SID1234598201]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Atomwise Chief Executive Officer and Co-Founder Abraham Heifets, Ph.D. will lead the presentation.

The Atomwise presentation is scheduled to take place on Monday, January 10, 2022, from 12:30 – 12:55 p.m. PT/3:30 – 3:55 p.m. ET.